CMS proposes denying coverage for seat elevation systems on Group 2 power wheelchairs
By HME News Staff
Updated 11:07 AM CST, Tue February 24, 2026
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has published a proposed local coverage determination (LCD) for a not reasonable and necessary determination for Group 2 power wheelchairs (PWCs) with seat elevation systems (K0830 and K0831) based on the best available evidence.
The agency states, per the national coverage determination (NCD) for seat elevation equipment (power operated) on power wheelchairs, coverage of Group 2 PWCs with seat elevators would be determined at the MAC’s discretion.
The National Coalition for Assistive & Rehab Technology (NCART) had this response to the news:
“On February 19th, nearly three years after the Centers for Medicare & Medicaid Services (CMS) affirmed Medicare coverage for power seat elevation on power wheelchairs, the Medicare DME MACs announced proposed changes to the Power Mobility Device Local Coverage Determination that states, Group 2 PWC with seat elevation systems (K0830, K0831) will be denied as not reasonable and necessary,” the organization stated in a bulletin. “NCART has formed a stakeholder workgroup to develop evidence-based information for physicians, clinicians, manufacturers, providers and beneficiaries to submit comments on the impact this proposal will have on access to medically necessary care. We ask all stakeholders to hold off submitting comments on this until we have completed a detailed analysis of the proposed change and communicated that to all interested parties with a clear and coordinated message.”
CMS will accept comments on the proposed LCD until April 4, 2026.
Comments